229 related articles for article (PubMed ID: 28754553)
21. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.
Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG
J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia triggers subcellular compartmental redox signaling in vascular smooth muscle cells.
Waypa GB; Marks JD; Guzy R; Mungai PT; Schriewer J; Dokic D; Schumacker PT
Circ Res; 2010 Feb; 106(3):526-35. PubMed ID: 20019331
[TBL] [Abstract][Full Text] [Related]
23. Ursodeoxycholic Acid Ameliorated Diabetic Nephropathy by Attenuating Hyperglycemia-Mediated Oxidative Stress.
Cao A; Wang L; Chen X; Guo H; Chu S; Zhang X; Peng W
Biol Pharm Bull; 2016 Aug; 39(8):1300-8. PubMed ID: 27193377
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy.
Ni R; Cao T; Xiong S; Ma J; Fan GC; Lacefield JC; Lu Y; Le Tissier S; Peng T
Free Radic Biol Med; 2016 Jan; 90():12-23. PubMed ID: 26577173
[TBL] [Abstract][Full Text] [Related]
25. Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy.
Jung E; Kim J; Ho Kim S; Kim S; Cho MH
Eur J Pharmacol; 2015 Aug; 761():116-24. PubMed ID: 25977232
[TBL] [Abstract][Full Text] [Related]
26. Live cell imaging of mitochondrial redox state in mammalian cells and yeast.
Liao PC; Franco-Iborra S; Yang Y; Pon LA
Methods Cell Biol; 2020; 155():295-319. PubMed ID: 32183963
[TBL] [Abstract][Full Text] [Related]
27. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
[TBL] [Abstract][Full Text] [Related]
28. Antioxidants ameliorate the expression of vascular endothelial growth factor mediated by protein kinase C in diabetic podocytes.
Lee EY; Chung CH; Kim JH; Joung HJ; Hong SY
Nephrol Dial Transplant; 2006 Jun; 21(6):1496-503. PubMed ID: 16484238
[TBL] [Abstract][Full Text] [Related]
29. The Role of TLR4 on PGC-1
Yuan S; Liu X; Zhu X; Qu Z; Gong Z; Li J; Xiao L; Yang Y; Liu H; Sun L; Liu F
Oxid Med Cell Longev; 2018; 2018():6296802. PubMed ID: 29861832
[TBL] [Abstract][Full Text] [Related]
30. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
[TBL] [Abstract][Full Text] [Related]
31. Klotho deficiency aggravates diabetes-induced podocyte injury due to DNA damage caused by mitochondrial dysfunction.
Chen Z; Zhou Q; Liu C; Zeng Y; Yuan S
Int J Med Sci; 2020; 17(17):2763-2772. PubMed ID: 33162804
[TBL] [Abstract][Full Text] [Related]
32. Coenzyme Q10 prevents GDP-sensitive mitochondrial uncoupling, glomerular hyperfiltration and proteinuria in kidneys from db/db mice as a model of type 2 diabetes.
Persson MF; Franzén S; Catrina SB; Dallner G; Hansell P; Brismar K; Palm F
Diabetologia; 2012 May; 55(5):1535-43. PubMed ID: 22311417
[TBL] [Abstract][Full Text] [Related]
33. Palmitic Acid-Induced Podocyte Apoptosis via the Reactive Oxygen Species-Dependent Mitochondrial Pathway.
Liu T; Chen XM; Sun JY; Jiang XS; Wu Y; Yang S; Huang HZ; Ruan XZ; Du XG
Kidney Blood Press Res; 2018; 43(1):206-219. PubMed ID: 29490300
[TBL] [Abstract][Full Text] [Related]
34. Restoring mitochondrial superoxide levels with elamipretide (MTP-131) protects
Miyamoto S; Zhang G; Hall D; Oates PJ; Maity S; Madesh M; Han X; Sharma K
J Biol Chem; 2020 May; 295(21):7249-7260. PubMed ID: 32277051
[TBL] [Abstract][Full Text] [Related]
35. G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes.
Wang XX; Edelstein MH; Gafter U; Qiu L; Luo Y; Dobrinskikh E; Lucia S; Adorini L; D'Agati VD; Levi J; Rosenberg A; Kopp JB; Gius DR; Saleem MA; Levi M
J Am Soc Nephrol; 2016 May; 27(5):1362-78. PubMed ID: 26424786
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Ceramide Accumulation in Podocytes by Myriocin Prevents Diabetic Nephropathy.
Woo CY; Baek JY; Kim AR; Hong CH; Yoon JE; Kim HS; Yoo HJ; Park TS; Kc R; Lee KU; Koh EH
Diabetes Metab J; 2020 Aug; 44(4):581-591. PubMed ID: 31701696
[TBL] [Abstract][Full Text] [Related]
37. Improving redox sensitivity of roGFP1 by incorporation of selenocysteine at position 147.
Stanford KR; Ajmo JM; Bahia PK; Hadley SH; Taylor-Clark TE
BMC Res Notes; 2018 Nov; 11(1):827. PubMed ID: 30466490
[TBL] [Abstract][Full Text] [Related]
38. Redox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and Podocytes.
Manda G; Checherita AI; Comanescu MV; Hinescu ME
Mediators Inflamm; 2015; 2015():604208. PubMed ID: 26491232
[TBL] [Abstract][Full Text] [Related]
39. Melatonin protects podocytes from angiotensin II-induced injury in an in vitro diabetic nephropathy model.
Ji ZZ; Xu YC
Mol Med Rep; 2016 Jul; 14(1):920-6. PubMed ID: 27220903
[TBL] [Abstract][Full Text] [Related]
40. Genetically encoded reactive oxygen species (ROS) and redox indicators.
Pouvreau S
Biotechnol J; 2014 Feb; 9(2):282-93. PubMed ID: 24497389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
